In patients treated with lomustine single agent , higher absolute CEC numbers after 4 weeks ( logCEC hazard ratio ( HR ) 0.41 , 95 % CI 0.18-0 .91 ) and 6 weeks ( logCEC HR 0.16 , 95 % CI 0.05-0 .56 ) of treatment were associated with improved overall survival ( OS ) .